MiNK Therapeutics, Inc.
INKT
$8.41
-$0.34-3.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 808.90K | 1.16M | 1.06M | 1.28M | 2.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -62.70K | 180.90K | -- | -- | -- |
| Total Operating Expenses | 4.37M | 1.88M | 2.90M | 3.83M | 5.50M |
| Operating Income | -4.37M | -1.88M | -2.90M | -3.83M | -5.50M |
| Income Before Tax | -2.46M | -1.81M | -2.70M | -3.81M | -5.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.46M | -1.81M | -2.70M | -3.81M | -5.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.46M | -1.81M | -2.70M | -3.81M | -5.46M |
| EBIT | -4.37M | -1.88M | -2.90M | -3.83M | -5.50M |
| EBITDA | -4.26M | -1.82M | -2.86M | -3.78M | -5.45M |
| EPS Basic | -0.62 | -0.46 | -0.73 | -1.10 | -1.58 |
| Normalized Basic EPS | -0.65 | -0.29 | -0.49 | -0.69 | -0.99 |
| EPS Diluted | -1.25 | -0.46 | -0.73 | -1.10 | -1.58 |
| Normalized Diluted EPS | -0.65 | -0.29 | -0.49 | -0.69 | -0.99 |
| Average Basic Shares Outstanding | 3.96M | 3.95M | 3.71M | 3.46M | 3.46M |
| Average Diluted Shares Outstanding | 3.96M | 3.95M | 3.71M | 3.46M | 3.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
